TwitterInstagramLinkedInFacebookRSS

College of Medicine student receives approval to begin clinical trial with drug to treat upper gastrointestinal cancers

  • Marketing & Communications
  • Medicine

(COLLEGE STATION, TX) Maen Abdelrahim, Ph.D., a first-year student in the Texas A&M Health Science Center College of Medicine, has received approval to begin early clinical trials with a drug to treat upper gastrointestinal cancers, including pancreatic cancer.

Media contact: media@tamu.edu

Share This

Related Posts

Bhuvaneshwaran Subramanian

College of Medicine scholar receives American Heart Association research fellowship

Nancy Dickey

Nancy Dickey named interim head of Texas A&M’s Department of Humanities in Medicine

red, glowing tumor in the center of an x-ray showing blue tinted bones around the tumor. Osteosarcoma

New interdisciplinary research lays groundwork for predicting if bone cancer will spread

Back To Top